Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Neogen Acquires Scidera Genomics

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Neogen plans to retain Scidera’s current employees and continue to operate from the company’s facilities in Davis.

Neogen Corporation has announced that it has acquired the assets of Scidera Genomics, LLC, an animal genomics business based in Davis, California.

The company, formerly operated as MetaMorphix, Inc., or MMI Genomics, was a pioneer in the development of cattle, poultry, swine, and canine genetic testing.

Scidera’s predecessor company conducted parentage testing and trait analysis for the cattle and canine industries since DNA was first used in the early 1990s.

The company owns critical patents and other intellectual property in the industry. Scidera also has had successful long-term customer relationships with influential dog breed registries, including the American Kennel Club, and numerous cattle breed associations, including the American Akaushi Association and American Bucking Bull, Inc.

“Scidera’s highly respected technical staff and customer base represent a perfect complement to Neogen’s animal genomics businesses, GeneSeek and Igenity,” said Dr. Jason Lilly, Neogen’s vice president of corporate development.

Dr. Lilly continued, “The combination of these companies within Neogen creates the unquestioned global leader in innovative animal genomics tools and analysis. We now provide value-added services to leading agricultural genetics providers, large national cattle associations, companion animal breed registries, university researchers, and numerous commercial cattle producers.”

The acquisition, effective as of Jan. 1, will be reported as a part of Neogen’s animal safety segment. Terms of the acquisition were not disclosed.

In April 2010, Neogen acquired GeneSeek, then considered the leading commercial agricultural service laboratory in the United States. GeneSeek’s customers included many of the world’s largest animal and animal health companies. In May 2012, Neogen acquired Igenity.

GeneSeek had conducted the genetic testing of samples for Igenity, and Igenity then used that information with its bioinformatics databases to identify the animal’s key production traits.

Acquiring Scidera further adds to the genotyping testing technology Neogen can offer to world-wide animal genomics customers.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns.

Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Animal Health to Market Neogen's Dairy Genomic Program
Agreement to market Neogen's Igenity® Dairy Heifer Program.
Saturday, September 20, 2014
Neogen acquires Igenity from Merial
Igenity will operate as a part of Neogen's GeneSeek subsidiary, which already has a significant place in the worldwide animal genomics business.
Tuesday, May 01, 2012
Scientific News
Known Genetic Risk Factors for Endometrial Cancer Doubles
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Genetic Variant May Help Explain Why Labradors Are Prone To Obesity
A genetic variation associated with obesity and appetite in Labrador retrievers – the UK and US’s favourite dog breed – has been identified by scientists at the University of Cambridge. The finding may explain why Labrador retrievers are more likely to become obese than dogs of other breeds.
How Scientists Use DNA to Track Disease Outbreaks
They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?
Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings
Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Childhood Asthma Research Receives $2M
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!